期刊论文详细信息
BMC Nephrology
Characteristics of South African patients presenting with kidney disease in rural KwaZulu-Natal: a cross sectional study
Saraladevi Naicker2  Alain G H Assounga3  Gertrude P Thusi3  Nomandla D Madala1 
[1] Department of General Internal Medicine, Division of Internal Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa;Division of Nephrology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;Department of Nephrology, Division of Internal Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
关键词: South Africans;    Rural;    Hypertension;    HIV;    Dyslipidaemia;    Diabetes;    Chronic kidney disease;   
Others  :  1082701
DOI  :  10.1186/1471-2369-15-61
 received in 2013-10-28, accepted in 2014-04-02,  发布年份 2014
PDF
【 摘 要 】

Background

Diabetes mellitus is the leading cause of end-stage renal disease (ESRD) globally. Diabetes and human immunodeficiency virus (HIV), both prevalent in South Africa, have not been reported as significant causes of ESRD.

Methods

We evaluated chronic kidney disease (CKD) and cardiovascular disease risk factors in a cross-sectional study of 302 patients (165 females/ 137 males) at a CKD clinic in rural northern KwaZulu-Natal. We included all CKD outpatient clinic attendees and excluded acute renal failure patients. Demographic, clinical and laboratory data collected were analyzed with Stata11 software. Logistic regression analysis was used to determine factors associated with advanced CKD and results expressed as the odds ratio with the 95% confidence interval [OR (95% CI)].

Results

Of 302 patients analyzed, 290 (96%) were black African. Mean age ± SD was 47.1 ± 17.0 years. Approximately 86.4% of females and 54.5% of males were overweight/ obese. Dyslipidaemia was observed in 47.9% females and 29.2% males (P < 0.001). Estimated glomerular filtration rate (eGFR) was <30 ml/min/1.73 m2 in 50.6% patients. CKD risk factors observed were: hypertension (77.8%), diabetes (29.8%), HIV (28.5%), glomerulonephritis (7.0%) and tubulointerstitial diseases (5.6%). Independent factors associated with eGFR <30 ml/min/1.73 m2 at presentation were: HIV [OR = 2.4 (1.3-4.2), P = 0.004] and hypertension [OR = 2.3 (1.3-4.2), P = 0.007].

Conclusion

Diabetes and HIV are prevalent in CKD patients at primary/regional level healthcare in South Africa. With registry data lacking, dedicated CKD clinics at lower healthcare levels may provide valuable data on CKD epidemiology including changes in aetiology. Primary healthcare practitioners are faced with advanced CKD patients in resource-poor settings, with limited opportunity for upward referral hence the need for nephrology outreach programs.

【 授权许可】

   
2014 Madala et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20141224174954671.pdf 352KB PDF download
Figure 4. 16KB Image download
Figure 3. 22KB Image download
Figure 2. 13KB Image download
Figure 1. 17KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Naicker S: End-stage renal disease in sub-Saharan and South Africa. Kidney Int 2003, 63(Suppl 83):119-122.
  • [2]Atkins RC, Zimmet P: Diabetic kidney disease: act now or pay later. Acta Diabetol 2010, 47:1-4.
  • [3]Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie J, Lambert V, Mbananga N: Obesity in South Africa: the South African demographic and health survey. Obes Res 2002, 10(10):1038-1048.
  • [4]Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D: The burden of non-communicable diseases in South Africa. Lancet 2009, 374:934-947.
  • [5]Moosa MR, Kidd M: The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006, 70(6):1107-1114.
  • [6]South African Renal Society, South African Transplant Society, Southern African HIV Clinicians Society: Guidelines for renal replacement therapy in HIV-infected individuals in South Africa. S Afr J HIV Med 2008, 9(2):34-42.
  • [7]Weiner DE: Public health consequences of chronic kidney disease. Clin Pharmacol Ther 2009, 86(5):566-569.
  • [8]Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention. Circulation 2003, 108:2154-2169.
  • [9]Dirks JH, De Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ, International Society of Nephrology Commission for the Global Advancement of Nephrology Study Group 2004: Prevention of chronic kidney and vascular disease: toward global health equity - The Bellagio 2004 Declaration. Kidney Int 2005, 68(Suppl 98):S1-S6.
  • [10]Hallan SI, Stevens P: Screening for chronic kidney disease: which strategy? J Nephrol 2010, 23(02):147-155.
  • [11]Smith JM, Mott SA, Hoy WE, International Federation of Kidney Foundations: Status of chronic kidney disease prevention programs: international Federation of Kidney Foundation Members 2005/2007. Kidney Int 2008, 74(12):1516-1525.
  • [12]Katz I, Schneider H, Shezi Z, Mdleleni G, Gerntholtz T, Butler O, Manderson L, Naicker S: Managing type 2 diabetes in Soweto–The South African chronic disease outreach program experience. Prim Care Diabetes 2009, 3(3):157-164.
  • [13]Statistics South Africa: Provincial profile - KwaZulu-Natal. Report No. 00-91-052004. http://www.statssa.gov.za/publications/Report-00-91-05/Report-00-91-052004.pdf webcite (Accessed 21st January 2014)
  • [14]Monticelli F, Day C, Barron P: District health baromater 2007/2008. Indicator comparisons by district: socio-economic indicators. http://www.hst.org.za/uploads/files/dhb0708_sec1.pdf webcite (Accessed 29th January 2013)
  • [15]Levey AS, Stevens LA, Schmid CH: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150(9):604-612.
  • [16]Schwartz GJ, Haycock GB, Edelman CM, Spitzer A: A simple estimation of glomerular filtration rate in children derived from body weight and plasma creatinine. Pediatrics 1976, 58:259-263.
  • [17]Van Deventer HE, George JA, Paiker JE, Becker PJ, Katz IJ: Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chemistry 2008, 54(7):1197-1202.
  • [18]Eastwood JB, Kerry SM, Plange-Rhule J, Micah FB, Antwi S, Boa FG, Banerjee D, Emmett L, Miller MA, Cappuccio FP: Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations. Nephrol Dial Transplant 2010, 25(7):2178-2187.
  • [19]Madala ND, Nkwanyana N, Dubula T, Naiker IP: Predictive performance of eGFR equations in South Africans of African and Indian ancestry compared with (99 m)Tc-DTPA imaging. Int Urol Nephrol 2012, 44(3):847-855.
  • [20]van Rensburg BW, van Staden AM, Rossouw GJ, Joubert G: The profile of adult nephrology patients admitted to the Renal Unit of the Universitas Tertiary Hospital in Bloemfontein, South Africa from 1997 to 2006. Nephrol Dial Transplant 2010, 25(3):820-824.
  • [21]Okpechi I, Swanepoel C, Duffield M, Mahala B, Wearne N, Alagbe S, Barday Z, Arendse C, Rayner B: Patterns of renal disease in Cape Town South Africa: a 10-year review of a single-centre renal biopsy database. Nephrol Dial Transplant 2011, 26(6):1853-1861.
  • [22]Han TM, Naicker S, Ramdial PK, Assounga AGH: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006, 69(12):2243-2250.
  • [23]Navaneethan SD, Aloudat S, Singh S: A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol 2008, 9:3.
  • [24]Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL: Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 2008, 121(4):332-340.
  • [25]Peer N, Steyn K, Dennison CR, Levitt NS, Nyo MT, Nel JH, Commerford PJ, Fourie JM, Hill MN: Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi-Hi study. Am J Hypertens 2008, 21(8):896-902.
  • [26]Gold CH, Isaacson C, Levin J: The pathological basis of end-stage renal disease in blacks. S Afr Med J 1982, 61(8):263-265.
  • [27]Seedat YK, Naicker S, Rawat R, Parsoo I: Racial differences in the causes of end-stage renal failure in Natal. S Afr Med J 1984, 65(24):956-958.
  • [28]Veriava Y, du Toit E, Lawley CG, Milne FJ, Reinach SG: Hypertension as a cause of end-stage renal failure in South Africa. J Hum Hypertens 1990, 4(4):379-383.
  • [29]Arogundade FA, Barsoum RS: CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 2008, 51(3):515-523.
  • [30]Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD: Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008, 197(11):1548-1557.
  • [31]Alebiosu CO, Ayodele OE: The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria. Trop Dr 2006, 36:218-219.
  • [32]Karaye KM, Habib AG: Dyslipidaemia in patients with established cardiovascular disease in Sub-Saharan Africa: a systematic review and meta-analysis. Eur J Prev Cardiol 2012. Epub 2012 September 5. Pubmed PMID: 22952291
  • [33]Harper CR, Jacobson TA: Managing dyslipidemia in chronic kidney disease. J Am Coll Cardiol 2008, 51(25):2375-2384.
  • [34]Murthy K, Stevens LA, Stark PC, Levey AS: Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. Kidney Int 2005, 68(4):1884-1887.
  • [35]Eppenga W, van Luin M, Richter C, Derijks H, De Smet P, Wensing M: The validity of the modification of diet in renal disease formula in HIV-infected patients: a systematic review. J Nephrol 2014, 27(1):11-18.
  文献评价指标  
  下载次数:49次 浏览次数:11次